Drug recall: Lupin recalls 4,113 cartons of oral contraceptive

The USFDA has classified both the recalls as class III.

Picture: Pixabay

Last Updated on December 14, 2021 by The Health Master

Homegrown drug maker Lupin is recalling 4,113 cartons of generic oral contraceptive tablets in the US, the world’s largest market for medicines, due to manufacturing issues.

As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Lupin’s US-based unit is recalling 4,113 cartons of Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg).

The affected lot has been produced at the company’s Pithampur-based manufacturing facility in Madhya Pradesh and distributed in the US by Baltimore-based Lupin Pharmaceuticals, Inc.

The company is recalling the lot due to it being a “subpotent drug,”, the US health regulator noted in the report. Lupin initiated the nationwide recall on November 19 of this year, it added.

The USFDA has classified both the recalls as class III.

As per the US health regulator, a class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences”.

Last month, the USFDA had stated that the Mumbai-based drug maker is recalling 16,272 bottles of Gatifloxacin Ophthalmic solution, an antibiotic used to treat bacterial infections of the eyes, in the US market.

As per the US health regulator, the company’s US-based unit is recalling the affected lot due to “failed stability specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration”.

The affected lot was also manufactured at the company’s Pithampur-based plant.

The US generic drug market was estimated to be around USD 115.2 billion in 2019. It is the largest market for pharmaceutical products.

Drug recall: Aurobindo, Unichem recall these drugs from the market

Drug recall: Sun Pharma recalls about 1.10 lakh bottles of Tadalafil in US market

Drug recall: Sun Pharma, Lupin recall products due to these reasons

Drug recall: Cook Medical recalled these Medical Devices

Drug recall: BP medicine recalled due to this reason

Drug recall: Merck recalls Daptomycin for Injection 500mg

ICMR designs kit to detect new variant Omicron in 2 hours

Inquiry needed into unfair trade practice of discount pricing by Medical…

Marksans Pharma gets UK MHRA nod for Diarrhoea medication

Zydus Cadila gets USFDA nod for generic Schizophrenia drug

High Court quashed the criminal complaint of alleged NSQ drug

Medical treatments may get more expensive for you from next year

Increase in Pharmacy colleges to meet rising demand of Medical Stores

IPC flags safety alert against NSAID Diclofenac

Procedure for registration of Medical Devices: CDSCO

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner